Observations placeholder

Etanercept and Enbrel

Identifier

017718

Type of Spiritual Experience

Hallucination

Number of hallucinations: 223

Background

A description of the experience

Etanercept

trade name Enbrel, is a  TNF inhibitor. It is used to treat rheumatoid, juvenile rheumatoid and psoriatic arthritis, plaque psoriasis and ankylosing spondylitis. 

On Jan, 19, 2017 375,857 people reported to have side effects when taking Enbrel.
Among them, 173 people (0.05%) have Hallucination

On Jan, 04, 2017 375,857 people reported to have side effects when taking Enbrel.  Among them, 50 people (0.01%) have Hallucination, Auditory

Time on Enbrel when people have Hallucination  :

  < 1 month 1 - 6 months 6 - 12 months 1 - 2 years 2 - 5 years 5 - 10 years 10+ years
Hallucination 24.00% 32.00% 8.00% 16.00% 8.00% 12.00% 0.00%

Gender of people who have Hallucination when taking Enbrel  :

  Female Male
Hallucination 71.90% 28.10%

Age of people who have Hallucination when taking Enbrel  :

  0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Hallucination 0.00% 1.15% 0.00% 2.30% 9.20% 10.34% 26.44% 50.57%

The source of the experience

eHealthme

Concepts, symbols and science items

Concepts

Symbols

Science Items

TNFs

Activities and commonsteps

Commonsteps

Hearing voices

References